scholarly journals ePS3.06 Quantifying moderate to vigorous physical activity using heart rate in children and young people with cystic fibrosis

2019 ◽  
Vol 18 ◽  
pp. S46 ◽  
Author(s):  
H. Douglas ◽  
E. Raywood ◽  
K. Kapoor ◽  
N. Correvon ◽  
G. Davies ◽  
...  
Keyword(s):  
Physical Activity ◽  
Cystic Fibrosis ◽  
Heart Rate ◽  
Young People ◽  
Vigorous Physical Activity ◽  
Children And Young People

scholarly journals Physical activity levels of children with visual impairments during an adapted sports camp

2017 ◽  
Vol 35 (2) ◽  
pp. 143-153 ◽  
Author(s):  
Daniel W Tindall ◽  
John T Foley ◽  
Micheal W Beets ◽  
Lauren J Lieberman
Keyword(s):  
Physical Activity ◽  
Young People ◽  
Vigorous Physical Activity ◽  
Visual Impairments ◽  
Activity Levels ◽  
Children And Young People ◽  
Disability Sports ◽  
Study Support ◽  
Adapted Sports ◽  
Children With Visual Impairments

The purpose of this study was to identify the physical activity (PA) levels of children and young people with visual impairments (VI) as they participated in closed and open skilled sports as part of a specially designed 1-week sports camp. Participants ( N = 18; girls = 6; boys = 12; Mage = 13 years, 4 months) aged 9–19 years possessed various levels of VI. Data were collected using Actigraph GM1 accelerometers and analysed using a one-way analysis of variance (ANOVA). Findings suggest there was a significant effect of activity type on both intensity F(1.7,28.94) = 9.86, p = .001, [Formula: see text] and time spent in moderate-to-vigorous physical activity (MVPA) F(4,68) = 6.03, p < .001, [Formula: see text]. The findings of this study support the continued implementation of both closed and open skill-oriented disability sports as a means to reaching recommended MVPA levels for children and young people with VI.

scholarly journals Do you mind if I take your blood pressure? Physical health monitoring of children and young people on ADHD medication amidst a pandemic

BJPsych Open ◽  
2021 ◽  
Vol 7 (S1) ◽  
pp. S183-S184
Author(s):  
Emma Davies ◽  
Maham Khan ◽  
Claire Jones
Keyword(s):  
Blood Pressure ◽  
Heart Rate ◽  
Young People ◽  
Physical Health ◽  
Health Monitoring ◽  
Neurodevelopmental Disorder ◽  
Adhd Medication ◽  
Children And Young People ◽  
Nice Guidance ◽  
The Impact

AimsTo establish whether physical health monitoring for CYP on ADHD medication is according to NICE guidance (2018).To determine the impact of COVID-19 pandemic restrictions on physical health monitoring for CYP on ADHD medication.Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, characterised by a persistent pattern of inattention and/or hyperactivity-impulsivity, directly impacting on academic, occupational, or social functioning. It affects between 1-5% of children and young people (CYP) most often presenting in early-mid childhood.Pharmacological treatment can be considered in CYP if certain criteria are met, where licensed medications include methylphenidate, dexamfetamine, lisdexamfetamine, atomoxetine and guanfacine. Stimulant and non-stimulant medications require frequent physical health monitoring due to their side effects including an increase in blood pressure and/or heart rate, loss of appetite, growth restriction and tics.MethodStandards and criteria were derived from the NICE guidance (2018), whilst local trust policies were reviewed, demonstrating discrepancies. Standards were expected to be met for 100% of patients.Electronic patient records were reviewed retrospectively from a representative cohort of CYP reviewed by clinicians in a community CAMHS service during March-November 2020. Data were entered manually into a spreadsheet for evaluation.ResultA total of 27 CYP records were reviewed, average age 13yo, on a range of stimulant/non-stimulant preparations.5 (19%) had height checked every 6 months, with 4 delayed to 7-8 months.For those >10yo, only 5 (19%) had weight checked every 6 months.Only 2 (7%) had their height and weight plotted on a growth chart and reviewed by the healthcare professional responsible for treatment.Just 4 (15%) had heart rate and blood pressure recorded before and after each dose change, whilst similarly only 4 (not the same) had these parameters recorded every 6 months.17 patients were reviewed by telephone/video call, where 5 patients provided physical health parameters (measured at home).ConclusionAcross all parameters, standards are not being met for the required physical health monitoring for CYP on ADHD medication.The COVID-19 pandemic has significantly changed the working conditions for community teams, impacting face to face reviews, creating challenges for physical health monitoring.Our ongoing implementations for change include the use of a proforma for physical health measurements, improving psychoeducation for families, exploring potential barriers with senior colleagues and collaborating with pharmacy colleagues to update local guidelines in accordance with the latest NICE recommendations. We aim to re-audit in June 2021.

Investigating the Measurement of Physical Activity and Associated Factors in Youth and Adults with Cystic Fibrosis

2021 ◽  
Author(s):  
◽  
Mayara S. Bianchim
Keyword(s):  
Physical Activity ◽  
Cystic Fibrosis ◽  
Lung Function ◽  
Vigorous Physical Activity ◽  
The Body ◽  
Machine Learning Algorithms ◽  
Cut Points ◽  
Measurement And Analysis ◽  
The Relationship ◽  
Crucial Part

Cystic Fibrosis (CF) is a multisystemic condition that affects almost every organ in the body, but especially the lungs. Regular physical activity (PA) can significantly slow disease progression and has become a crucial part of CF care. Previous research evaluating PA in CF has been hindered by the use of cut-points developed for healthy populations and the investigation of collinear movement behaviours as independent entities, both of which are likely to have confounded their findings and any subsequent inferences regarding associated health outcomes. Therefore, the overall aim of this thesis was to investigate the measurement and analysis of PA in those with CF. An initial systematic review provided recommendations for research calibrating accelerometry in paediatric clinical populations, highlighting that the pathophysiology of the condition must be accounted for and that the protocol should include a broad range of activities varying in intensity (Chapter 4). Subsequently, Chapter 5 developed and cross-validated raw acceleration CF-specific cut-points in youth which were then further assessed in Chapter 6, demonstrating that the CF-specific thresholds were associated with higher levels of moderate-to-vigorous physical activity (MVPA) and sedentary time (SED) and lower levels of light PA compared to generic cut-points. Furthermore, lung function was associated with light PA when using condition-specific thresholds. Further investigation of the relationship between PA and health in Chapter 7 found that reallocating time from sedentary to any other behaviour was beneficial for lung function, with the greatest improvements observed when SED was reallocated to sleep or MVPA. Finally, Chapter 8 developed and validated machine learning algorithms that achieved excellent accuracy to classify PA types and intensities in youth with CF. In conclusion, these findings significantly advance the assessment of PA, enhancing our understanding of the relationship between PA and health in CF and informing future condition-specific PA guidelines, care strategies and interventions.

scholarly journals Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis

2020 ◽  
Author(s):  
Noreen Zainal Abidin ◽  
Aaron Ions Gardner ◽  
Hannah-Louise Robinson ◽  
Iram J. Haq ◽  
Matthew F. Thomas ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Young People ◽  
Nontuberculous Mycobacteria ◽  
Children And Young People
Sign in / Sign up

Export Citation Format

Share Document